Follow Us:
About

About

CELLINK

CELLINK is the first bioink company in the world and the leading bioprinting technology provider. The company focuses on the development and commercialization of bioprinting technologies that allow researchers to 3D print human organs and tissues for the development of pharmaceutical and cosmetic products, and in the future, for clinical applications. CELLINK’s innovative and patent pending bioink is a biomaterial innovation that enables human cells to grow and thrive such as they would in the natural human body environment. Today, the company’s disruptive technology platform is being utilized to print tissues such as liver, cartilage, skin, and even fully functional cancer tumors that can then be used to develop new cancer treatments. The company has, within 12 months, been able to commercialize products in more than 40 countries and sold to more than hundreds of prestigious labs around the world, such as Harvard, MIT, Princeton, and FDA. Follow us on our journey to change the world of medicine.

Users

Academic users

World map
  • CELLINK
  • Distributor
USA40%
Europe30%
Rest of the world30%
Founded
2016
+40 Countries
+400 labs
+75 employees
Forbes: 30 Under 30 2018
Erik Gatenholm placed on Forbes 30 Under 30 2018!
TEDx
Hector Martinez featured at TEDx in Germany on February 3rd!
Nordic Health Startup of the Year!
Nordic Health Startup of the Year
Listing CELLINK on the NASDAQ Stock Exchange!
CELLINK IPO in November 2016
Anders Wall Entrepreneurship Award!
Erik Gatenholm wins the Anders Wall Entrepreneurship Award 2017
Arvid Carlsson Entrepreneurship Award!
CELLINK wins the Arvid Carlsson Entrepreneurship Award 2017